| Aß | Amyloid-ß |
| AD | Alzheimer’s disease |
| AIM2 | Absent in melanoma 2 |
| AKT | Protein kinase B |
| ALS | Amyotrophic lateral sclerosis |
| APP | Amyloid precursor protein |
| ASC | Apoptosis-associated speck-like protein containing a caspase recruitment domain |
| BBB | Blood-brain barrier |
| CARD | Caspase activation and recruitment domain |
| Casp1 | Caspase 1 |
| CNS | Central nervous system |
| DAMPs | Damage-associated molecular pattern molecules |
| IGF-1 | Insulin-like growth factor-1 |
| IL | Interleukin |
| JAK/STAT | Janus kinases/Signal transducer and activator of transcription proteins |
| LPS | Lipopolysaccharides |
| MAPK | Mitogen-activated protein kinases |
| MDD | Major depressive disorder |
| MS | Multiple sclerosis |
| NF-κB | Nuclear factor-kappa B |
| NLRC4 | NLR family CARD domain-containing protein 4 |
| NLRP | NACHT, LRR, and PYD domains-containing protein |
| NLRs | Nucleotide-binding oligomerization domain and leucine-rich repeat-containing receptors |
| PAMPs | Pathogen-associated molecular pattern molecules |
| PET | Positron emission tomography |
| PI3K | Phosphatidylinositol 3-kinase |
| PPR | Pattern recognition receptor |
| PGE2 | Prostaglandin E2 |
| P2X4/P2RX7 | Purinergic receptor subtypes |
| ROS | Reactive oxygen species |
| TLRs | Toll-like receptors |
| TSPO | Translocator protein |
| TSPO VT | Translocator protein total volume |
| VPL | Ventroposterior lateral thalamic nucleus |
| VPM | Ventroposterior medial thalamic nucleus |